We previously reported that an acidomycin-resistant mutant of Serratia marcescens Sr41, SB304, and a mutant that was derived from SB304 and was resistant to a higher concentration of acidomycin, SB412, produced 5 and 20 mg of D-biotin, respectively, per liter of a medium containing sucrose and urea (N. Sakurai, Y. Imai, M. Masuda, S. Komatsubara, and T. Tosa, Appl. Environ. Microbiol. 59:2857Microbiol. 59: -2863Microbiol. 59: , 1993. In order to increase the productivity of D-biotin, the biotin (bio) operons were cloned from strains SB412, SB304, and 8000 (wild-type strain), and pLGM412, pLGM304, and pLGW101, respectively, were obtained through subcloning. These plasmids harbored 7.2-kb DNA fragments coding for the bioABFCD genes on a low-copynumber vector and were introduced into SB304, SB412, and 8000. Among the resulting recombinant strains, SB412(pLGM304) exhibited the highest D-biotin production (200 mg/liter) in the production medium. The plasmid was stably maintained in cells. Unexpectedly, SB412(pLGM412) grew very slowly, and the D-biotin productivity of this recombinant strain was not evaluated because pLGM412 was unstable.
In microorganisms, D-biotin is synthesized from pimeloyl coenzyme A (pimeloyl-CoA) in four enzymatic steps. The precursors of pimeloyl-CoA are still unclear, although some microorganisms have been reported to be capable of converting pimelic acid to pimeloyl-CoA (15) . In Escherichia coli, the biosynthetic pathway from pimeloyl-CoA to D-biotin involves 7-keto-8-aminopelargonic acid (KAPA), 7,8- diaminopelargonic acid (DAPA), and dethiobiotin. The five biotin-biosynthetic enzymes are encoded by the biotin (bio) operon and are subject to strict feedback repression by biotin ( Fig. 1) (1, 10) . However, no one knows what mechanism is involved in the introduction of the sulfur atom into dethiobiotin and what kind of sulfur compounds participate in this reaction, despite many studies (9, 13, 26) .
D-Biotin is a commercially important vitamin which is used mainly as an animal feed additive. It is known that D-biotin functions as the carrier of carbon dioxide in enzymatic carboxylation and transcarboxylation reactions (16) . At present, this vitamin is manufactured industrially by using a complex chemical synthesis process (12) .
Several research groups have been competing to develop fermentative methods for D-biotin production, and a lot of effort has been directed toward the construction of D-biotinproducing strains (3, 11, 14, 19, 27, 30, 36) . Recombinant strains of E. coli and Bacillus sphaenicus have been constructed by cloning the genes involved in the synthesis of D-biotin (3, 11, 14, 25, 27) . We have estimated that the production of D-biotin is unlikely to be high enough for application to industrial fermentation when these recombinant strains are used; that is, fermentation methods require much higher levels of production to be cost competitive with the commercial chemical synthetic methods.
We previously reported that Serratia marcescens mutant SB412, which is very resistant to the biotin analog acidomy-cin, produced 20 mg of D-biotin per liter (28) . This strain was found to be highly constitutive for biotin-biosynthetic enzymes. In our laboratory, various L-amino-acid-producing strains of S. marcescens were improved by cloning related genes, and some of these strains have been used commercially (32) (33) (34) (35) . We are therefore acquainted with the genetic characteristics of S. marcescens and know how to apply gene cloning techniques to strain improvement.
With the background described above, we intended to apply gene cloning techniques to the construction of a D-biotin-hyperproducing strain of S. marcescens. In this paper we describe cloning of the wild-type and mutant bio operons, how we determined the mutations involved in D-biotin overproduction, and the gene dosage effect of the bio operon on D-biotin production by S. marcescens.
MATERIALS AND METHODS
Strains, plasmids, and media. The derivatives of E. coli K-12 and S. marcescens Sr4l and the plasmids used are listed in Table 1 . Nutrient medium containing 0.5% glucose, 1.0% peptone, 0.3% meat extract, 1.0% yeast extract, and 0.5% NaCl was used for routine colony isolation and for the growth study. The minimal medium of Davis and Mingioli (7) was modified by omitting sodium citrate and increasing the glucose concentration to 0.5%. For the complementation test in which E. coli X1776 was used, we used the minimal medium described above with 0.1% casein hydrolysate (vitamin free), 0.01% a,e-diaminopimelic acid, and 0.004% thymidine added. Antibiotics were added at the following concentrations for E. coli K-12: kanamycin, 100 ,ug/ml; ampicillin, 100 ,ug/ml; tetracycline, 10 ,ug/ml; and streptomycin, 50 pLg/ml. For S. marcescens antibiotics were added at the following concentrations: kanamycin, 200 ,ug/ml; and ampicillin, 500 ,g/ml. Medium F2, which was used for D-biotin production, contained 15% sucrose, 1.5% urea, containing medium F2 under conditions described previously (28) . Growth was estimated as described previously (28) .
Growth study. To measure the growth rate, cells grown on a nutrient agar slant overnight were washed twice with cold saline and inoculated into a medium to give 5 x 107 cells per ml, and the resulting culture was grown at 30°C in a shaking flask containing 100 ml of minimal medium. Portions were removed at 1-h intervals to measure the turbidity at the exponential growth phase. Growth was evaluated by measuring A660 with a Hitachi model U-1000 electric photometer.
Cloning of the bio operons. The chromosomal DNA of S. marcescens was prepared as described previously for E. coli DNA (22) c The suffix T indicates recA56.
ery of the plasmid DNA and introduction of it into S. marcescens strains, which are not deficient in DNA restriction. Construction of derivatives from primary plasmids and pLGM304. To construct plasmids containing pLG339, a low-copy-number vector, 7.2-kb EcoRI-HindIII fragments carrying the bio operons from pBW101, pBM304, and pBM412 were ligated to pLG339 DNA digested completely by EcoRI and partially by HindIII, yielding pLGW101, pLGM304, and pLGM412, respectively ( Cloning and subcloning of the bio operon from SB304. The mbio304 fragment was obtained by shotgun cloning and was subcloned onto pLG339, yielding pLGM304 as described in Materials and Methods. The bio operons were also cloned from wild-type strain 8000 and SB412. pLGW101 (pLG339::wbio) and pLGM412 (pLG339::mbio4,2) were constructed by using the method used for construction of pLGM304. Abbreviations: E, EcoRI; H, HindIll; B, BamHI; P, PvuII; Sa, SalI; Sc, Sacl; Sm, SmaI; Sp, SphI; Hc, HincII.
pLGM304 DNA was digested completely by BamHI and then partially by HindIII, and then the cohesive ends were repaired with the Klenow fragment to create blunt ends and the DNA was recircularized by ligation. The resulting plasmid, pLGM304dA, lacked the 1.5-kb HindIII-BamHI fragment carrying part of the bioA gene. To inactivate the bioB gene, pLGM304 DNA was digested by SacI, and the cohesive ends were treated with mung bean nuclease to generate pLGM304dB, whose bioB gene was inactivated because four nucleotides were deleted. To inactivate the bioF gene, the 0.35-kb StuI fragment was removed from pLGM304 DNA, and this was followed by selection of pLGM304dF. The Enzyme assays of DAPA aminotransferase and dethiobiotin synthetase. Cells were cultured in a minimal medium at 30°C with shaking, and cell extracts were prepared from exponentially growing cells by the method described previously (28) .
The activities of DAPA aminotransferase and dethiobiotin synthetase were determined as described previously (28 
RESULTS
Cloning of the bio operons from two D-biotin-producing strains and the wild-type strain. We intended to increase D-biotin production by elevating the levels of biotin-biosynthetic enzymes. First, the bio operons were cloned from S. marcescens SB412, which has the highest D-biotin-producing activity known, and SB304, which is a parent strain of SB412 and has lower productivity, by performing a shotgun cloning experiment in which pBR322 was the vector, X1776 was the host, and EcoRI and HindIII were the restriction enzymes (Fig. 2) . E. coli X1776 is deficient in the bioABFCD genes and the bioH gene because of deletion. Following the introduction of S. marcescens SB412 DNA in pBR322, Bio+ transformants of X1776 were selected on minimal agar plates containing KAPA, which complements the bioH deletion. The transforming DNA was tested for complementation of the biNA, -B, -F, -C, and -D mutants of E. coli, resulting in the identification of a 7.2-kb DNA fragment coding for the entire bio operon region. Next, a similar DNA fragment was cloned from strain 8000, the wild-type strain of S. marcescens Sr41, to compare the bio operons of mutant types and a wild type. We designated the resulting plasmids pBM412 (pBR322::mbio4,2), pBM304 (pBR322: :mbio304), and pBW101 (pBR322::wbio).
Subcloning of the bio operons into a low-copy-number plasmid. Plasmid pBR322 is frequently used as a vector for gene cloning, but the introduction of pBW101, pBM304, and pBM412 into SB412 caused strong growth inhibition in addition to segregational instability of the plasmids. Apparently, such instability was not suitable for practical use. Hence we separately subcloned the 7.2-kb fragments containing the two mutant and wild-type bio operons into a low-copy-number plasmid, pLG339, which yielded pLGW101 (pLG339::wbio), pLGM304 (pLG339::mbio304), and pLGM412 (pLG339::mbio412) (Fig. 2) . Plasmid vector pLG339 has a pSC101-derived replicon and has been reported to stably replicate at a level of five to six copies per chromosome in cells of S. marcescens (33 were measured by using cell extracts of SB412 and SB412(pLGM304). The levels of DAPA aminotransferase activity and dethiobiotin synthase activity were three-and sixfold higher (14 and 93 nmol/min/mg of protein, respectively) in SB412(pLGM304) than in host strain SB412 (5.6 and 15 nmol/min/mg of protein, respectively). In addition, the synthesis of these enzymes was not sensitive to biotinmediated feedback repression. Structure of the bio operons of S. marcescens. To locate the individual genes involved in the bio operon, we isolated independent derivatives of pLGM304 with TnJOOO (-yb) insertions, and insertion sites were mapped by restriction enzyme cleavage (Fig. 3A) . We obtained 26 To localize the bio genes more precisely, eight plasmids which prevented the complementation of various Biostrains of E. coli were constructed from pLGM304 (Fig. 3B) . One of these plasmids, deletion plasmid pLGM304dP, which lacks the 0.75-kb SacI-Scal fragment, did not complement all of the biNA, -B, -F, -C, and -D strains.
The results described above indicated that the bioB, -F, -C, and -D genes might be transcribed from a single promoter which lies within the 0.75-kb SacI-Scal segment, confirming that the bioB, -F, -C, and -D genes of S. marcescens form an operonic structure.
On the other hand, transcription of bioA might be independent of transcription of the bioBFCD cistron since deletion of the putative bioA region did not influence the expression of the other genes, whereas all of the bio genes were repressed by removing the 0.75-kb Sacl-ScaI fragment.
We deduced that the DNA fragment carrying these five genes was 5.8 kb long or longer. The approximate sizes of the bioA, bioB, bioF, bioC, and bioD genes seemed to be 1.3, 1.0, 1.1, 0.8, and 0.7 kb, respectively.
Contribution of each of the bio genes to D-biotin overproduction. To examine the contribution of the genes in the bio operon to D-biotin overproduction, we introduced the five types of deletion plasmids from pLGM304 into SB412 and tested for the production of D-biotin and biotin-related compounds ( Table 2) .
The strains carrying pLGM304dA (defective in the bioA gene), pLGM304dF (defective in the bioF gene), and pLGM304dD (defective in the bioD gene) produced the same amounts of D-biotin and biotin-related compounds as SB412(pLGM304). On the other hand, SB412(pLGM304dB), which was defective in the bioB gene of the plasmid, produced only 60 mg of D-biotin per liter, as did SB412, but produced more than 400 mg of biotin-related compounds per liter, as did SB412(pLGM304). SB412(pLGM304dC), from which the bioC gene was deleted, produced only small amounts of both D-biotin and biotin-related compounds, as did SB412.
The results described above indicated that overproduction of the bioB and bioC products played an important role in D-biotin overproduction but that amplification of the bicA, bioF, and bioD products might not be significant for D-biotin overproduction. In a bioautographic study Saccharomyces cerevisiae was used as an indicator organism; this organism can grow on D-biotin, dethiobiotin, KAPA, and DAPA. This study revealed that the recombinants described above accumulated no detectable amounts of biotin precursors other than dethiobiotin (data not shown).
Colony sizes and growth rates of the strains carrying the bio operon recombinant plasmids. As mentioned above, the recombinant strains carrying plasmid pLGM412 grew extremely poorly in both nutrient medium and medium F2. Hence, we examined the effects of various bio recombinant plasmids on colony size and compared the growth rates of the wild-type strain, D-biotin-producing mutants, and recombinant strains to determine the profile of growth inhibition.
Vector pLG339 had no effect on the colony sizes of wild-type strain 8000 and strain SB412, which formed smaller colonies than the wild-type strain. Recombinant plasmids pLGM304 and pLGM412 did not affect the growth of the wild-type strain but caused cells of SB412 to form smaller and much smaller colonies, respectively, although a number of unusually large colonies of SB412 (pLGM412) were formed among the small colonies. Next, we examined the frequency of larger SB412(pLGM412) colonies. Cells from 26 independent small colonies were spread on nutrient agar plates containing kanamycin. After pLGM304dA, pLGM304dB, pLGM304dF, pLGM304dC, pLGM304dD, pLGM304dBFCD , and pLGM304dP were constructed by inactivating bioA, bioB, bioF, bioC, bioD, bioBFCD, and the promoter region, respectively, as described in Materials and Methods. Abbreviations: E, EcoRI; H, HindIII; B, BamHI; Sa, Sall; Sac, SacI; Pm, PmaCI; St, StuI. (E), (H), (Sac), and (Pm) indicate EcoRI, HindIII, Sacl, and PmnaCI sites which were lost during construction of the derivatives of pLGM304. and pLGM412 caused SB412 to grow slowly and very slowly, respectively, but had no effect on the growth rate of 8000. These observations were consistent with the profile of colony sizes described above and, in addition, indicated that more D-biotin production was accompanied by slower growth, presumably because of the metabolic disorder.
DISCUSSION
Many research groups have been trying to develop fermentative methods for D-biotin production (3, 11, 14, 19, 27, 30, 36) . A recombinant strain of E. coli has been reported to produce 105 mg of D-biotin per liter in a jar fermentor under carefully controlled fed-batch culture conditions (14) . This level of production is the highest level among the levels that have been reported. In this study we found that a recombinant strain of S. marcescens carrying the mutant bio operon produced D-biotin at levels as high as 200 mg/liter in a shaking flask under conventional culture conditions. Higher levels of D-biotin production can be expected when culture conditions are optimized and more sugar is added to the cultures. This D-biotin-producing strain is a promising candidate for industrial production of D-biotin.
Why does a recombinant strain of S. marcescens produce such high levels of D-biotin? Basically, S. marcescens grows faster, produces higher cell yields in a simple medium, and has higher sugar-assimilating activity than E. coli. These characteristics allow S. marcescens to produce abundant metabolites, including D-biotin, if metabolic regulatory mechanisms are genetically removed (17, 18) . We previously reported that the biotin-biosynthetic enzymes in both SB304 and SB412 were free from biotin-mediated feedback repression (28) . By performing a transductional analysis we detected a mutation in the bio operon locus of SB412 for D-biotin overproduction but could not determine whether SB304 acquired genetic alterations in the bio operon locus. This study revealed that SB304 also contains a mutation in the bio operon locus, although the contribution of this mutation to D-biotin overproduction was less important than the contribution of the mutation carried by SB412.
In E. coli, the five biotin-biosynthetic enzymes are encoded by the biNA, -B, -F, -C, and -D genes, all of which are clustered on a single operon (4) . This operon is divergently transcribed leftward to the bioA gene and rightward to the bioBFCD genes (5) . Both types of transcription are coordinately repressed by the biotin operon repressor (birA) protein combined with biotin (10) . We demonstrated that the biNA, -B, -F, -C, and -D genes of S. marcescens are clustered in this order and that bioB, -F, -C, and -D are transcribed by a single promoter, indicating that these genes form an operon structure. This structure is very similar to the overall structure of the E. coli genes. In this study, we could not determine the transcriptional direction of biNA, but it might be similar to the transcriptional direction in the E. coli model.
As described above, we constructed recombinant plasmids pLGM304 and pLGM412 carrying the mutant bio operons from D-biotin-producing mutants SB304 and SB412, respectively, and this was followed by the construction of several recombinant strains. We expected that SB412 (pLGM412) might produce the highest levels of D-biotin since the bio operon of pLGM412 was cloned from SB412, which produced the most D-biotin among the acidomycinresistant mutants which we isolated (28) . Unexpectedly, we could not evaluate the actual production of D-biotin by this recombinant strain because of poor growth and the instability of the plasmid; that is, the introduction of pLGM412 impeded cell growth, and mutated plasmids arose that no longer overproduced D-biotin and became dominant in the culture, resulting in the low productivity.
The slow growth of SB412(pLGM412) described above might be explained as follows. It is possible that the metabolic disorder caused by biotin overproduction might result in slow growth. A 
